.Zevra Rehabs' uncommon ailment medicine seems to be to be on the road to authorization this autumn ...
.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene therapy failure has blown a $230 thousand ho...
.After greater than two decades of focus on neurodegenerative ailments, Swiss biotech air conditione...
.GSK has actually ditched a period 2 human papillomavirus (HPV) vaccine coming from its own pipeline...
.OS Therapies will definitely specify on the NYSE American sell substitution this morning by means o...
.ALX Oncology's phase 2 gastric cancer reaction price has actually weakened. After viewing its own C...
.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has actually disappointed desires, ...
.While Biogen's pharma peers are actually seeking for late-stage possessions with little danger, CEO...
.Instil Bio has been a biotech in search of a pipeline after it ditched its own lead properties over...
.Biogen has actually handed back rights to a very early Alzheimer's illness plan to Denali Rehabs, g...